Novartis’ Vasella elected chairman at Alcon

Novartis' chairman Daniel Vasella was elected board chairman of Alcon, increasing the Swiss drugmaker's grip of the U.S. eyecare company as it tries to buy the stake it does not already own. Alcon's Independent Director's Committee (IDC), which has r...

Full Story →